Waystar is exploring a potential sale of its healthcare payments software business, according to reports citing seven sources familiar with the matter. The company has reportedly engaged bankers to advise on the process, though plans remain subject to change.
The company went public in 2024, aiming to secure higher valuations by positioning itself as a software provider rather than a services firm. However, the stock has faced pressure due to investor concerns regarding the potential impact of artificial intelligence on software companies.
In the broader healthcare technology sector, Forus recently secured $150 million in a Series C funding round, achieving a valuation of $3 billion. Additionally, Verily Health announced new investments from Nvidia and existing backers on Sept. 9 to support AI deployment in healthcare data management.
